Esbriet Now FDA-Approved for Idiopathic Pulmonary Fibrosis
Earlier this month, a second province in Canada finally approved novel pulmonary fibrosis drug Esbriet (pirfenidone) for public funding, which is a giant leap towards improving the lives of thousands of individuals living with idiopathic pulmonary fibrosis…